(1S, 1ꢀR)-4-(Cyclohex-2-enyl-hydroxy-methyl)-benzoic acid
methyl ester (3c). Obtained as a clear oil (36 mg, 73%); absolute
stereochemistry assigned by analogy to compounds 3 and 16;
HPLC (Chiralcel OD-H [300 mm], heptane–propan-2-ol 95 : 5,
0.50 mL min−1, 23.5 min [minor], 27.8 min [major]) shows 80%
ee; mmax/cm−1 (deposited on KBr powder) 3507 (OH), 2928, 1723
(CO), 1436, 1280, 1112; dH (400 MHz; CDCl3) 1.42–1.70 (6H, m),
1.93 (2H, m), 2.46 (1H, br-s, OH), 3.86 (3H, s, COMe), 4.64 (1H,
d, J 5.9, CHOH), 5.35 (1H, d, J 10.2), 5.80 (1H, m), 7.35 (2H, d,
J 8.0, Ar–H), 7.95 (2H, d, J 8.0, Ar–H); dC (200 MHz; CDCl3)
18.5, 20.8, 22.6, 40.5, 49.5, 74.2 (COMe), 123.9, 125.0, 126.5,
127.0, 128.6, 145.5, 164.5; m/z (EI+) 215 (3%, M+), 166 (14%),
165 (100%); HRMS C15H18O3 246.1253 (requires 246.1256).
[a]2D2 +22.8 (c 1.00 in C6H6) (lit.,27 +45.0); HPLC (Chiralcel OD-H
[300 mm], heptane–propan-2-ol 99 : 1, 0.50 mL min−1, 35.2 min
[major], 39.0 min [minor]) shows 37% ee; 1H and 13C-NMR in full
agreement with literature.27
Acknowledgements
We thank The Leverhulme Trust (UK) for a European Fellowship
to G. P. H and general financial support.
References
1 For a recent review of this topic, see: B. M. Trost, J. Org. Chem., 2004,
69, 5813.
(1S, 1ꢀR)(Cyclohex-2-enyl)(p-tolyl)methanol (3d). Obtained as
a clear oil (33 mg, 82%); absolute stereochemistry assigned by
analogy to compounds 3 and 16; HPLC (Chiralpak AD [300 mm],
heptane–propan-2-ol 99 : 1, 1.00 mL min−1, 19.9 min [major],
21.2 min [minor]) shows 72% ee; 1H and 13C-NMR in full
agreement with literature.25
2 B. M. Trost and M. L. Crawley, Chem. Rev., 2003, 103, 2921.
3 H. C. Brown, K. S. Bhat and R. S. Randad, J. Org. Chem., 1987, 52,
3702.
4 M. Kimura, M. Shimizu, K. Shibata, M. Tazoe and Y. Tamaru, Angew.
Chem., Int. Ed., 2003, 42, 3392; Y. Tamaru, J. Organomet. Chem., 1999,
576, 215; Y. Tamaru, A. Tanaka, K. Yasui, S. Goto and S. Tanaka,
Angew. Chem., Int. Ed. Engl., 1995, 34, 787; Y. G. Yasui, T. Yajima, Y.
Taniseki, A. Fugami and Y. Tamaru, Tetrahedron Lett., 1993, 34, 7619.
5 G. Zanoni, S. Gladiali, A. Marchetti, P. Piccinini, I. Tredici and G.
Vidari, Angew. Chem., Int. Ed., 2004, 43, 846.
6 S. F. Zhu, Y. Yang, L. X. Wang, B. Liu and Q. L. Zhou, Org. Lett.,
2005, 7, 2333.
7 For a recent review on asymmetric allylation of aldehydes and
applications in synthesis, see: S. E. Denmark and J. Fu, Chem. Rev.,
2003, 103, 2763.
8 For key studies on the use of phosphoramidite ligands, see: B. L.
Feringa, Acc. Chem. Res., 2000, 33, 346; J. G. Boiteau, R. Imbos, A. J.
Minnaard and B. L. Feringa, Org. Lett., 2003, 5, 681; J. G. Boiteau,
A. J. Minnaard and B. L. Feringa, J. Org. Chem., 2003, 68, 9841; M.
van den Berg, A. J. Minnaard, R. M. Haak, M. Leeman, E. P. Schudde,
A. Meetsma, B. L. Feringa, A. H. M. de Vries, C. E. P. Maljaars, C. E.
Willans, D. Hyett, J. A. Boogers, H. J. W. Henderickx and J. G. de Vries,
Adv. Synth. Catal., 2003, 345(1–2), 308.
9 For recent applications of this ligand class, see: K. Li and A. Alexakis,
Tetrahedron Lett., 2005, 46, 5823; R. Weihofen, A. Dahnz, O. Tverskoy
and G. Helmchen, Chem. Commun., 2005, 28, 3541; R. Sebesta, M. G.
Pizzuti, A. J. Boersma, A. J. Minnaard and B. L. Feringa, Chem.
Commun., 2005, 13, 1711.
10 K. N. Gavrilov, S. E. Lyubimov, S. V. Zheglov, E. B. Benetsky and V. A.
Davankov, J. Mol. Catal. A: Chem., 2005, 231(1–2), 255; R. Imbos,
A. J. Minnaard and B. L. Feringa, Dalton Trans., 2003, 10, 2017.
11 For a recent review, see: K. J. Szabo´, Chem.–Eur. J., 2004, 10, 5268.
12 H. Kurosawa, A. Urabe, K. Miki and N. Kasai, Organometallics, 1986,
5, 2002.
(1S, 1ꢀR)(Cyclohex-2-enyl)(o-tolyl)methanol (3e). Obtained as
a clear oil (32 mg, 82%); absolute stereochemistry assigned
by analogy to compounds 3 and 16; HPLC (Chiralcel OD–H
[300 mm], heptane–propan-2-ol 99 : 1, 0.50 mL min−1, 27.4 min
[major], 32.3 min [minor]) shows 68% ee; mmax/cm−1 (deposited
on KBr powder) 3403 (OH), 2927, 1488, 1448, 1017, 760, 730;
dH (400 MHz; CDCl3) 1.40–1.80 (4H, m), 1.95 (2H, m), 2.27
(3H, ArMe), 2.42 (1H, m, CHCHOH), 4.80 (1H, dd, J 6.6, 2.6,
CHOH), 5.27 (1H, dd, J 10.3, 2.2), 5.77 (1H, m), 7.05–7.22 (3H,
m, Ar–H), 7.44 (1H, d, J 7.7, Ar–H); dC (200 MHz; CDCl3) 17.9,
19.6, 22.6, 23.7, 40.4, 71.8 (CHOH), 124.5, 124.6, 125.6, 126.5,
128.7, 128.9, 133.3, 139.6; m/z (EI+) 202 (1%, M+), 122 (9%), 121
(100%), 93 (25%), 91 (14%), 77 (11%); HRMS C14H18O 202.1361
(requires 202.1357).
(1S, 1ꢀR)(Cyclohex-2-enyl)(furan-2-yl)methanol (3f). Obtained
as a clear oil (28 mg, 80%); absolute stereochemistry assigned
by analogy to compounds 3 and 16; HPLC (Chiralcel OD–H
[300 mm], heptane–propan-2-ol 99 : 1, 0.50 mL min−1, 29.6 min
[major], 33.1 min [minor]) shows 60% ee; mmax/cm−1 (deposited
on KBr powder) 3399 (OH), 2927, 2856, 1448, 1148, 1009, 734;
dH (400 MHz; CDCl3) 1.42–1.58 (2H, m), 1.64–1.84 (3H, m),
1.88–2.00 (2H, m), 2.60 (1H, m, CHCHOH), 4.49 (1H, d, J 7.3,
CHOH), 5.33 (1H, dd, J 10.2, 2.2), 5.75 (1H, m), 6.21 (1H, d, J 2.9,
furyl-H), 6.28 (1H, dd, J 2.9, 1.9, furyl-H), 7.38 (1H, d, J 1.9,
furyl-H); dC (200 MHz; CDCl3) 19.4, 22.9, 23.6, 39.2, 69.8, 105.3,
108.6, 125.7, 128.6, 140.3, 157.5; m/z (EI+) 178 (6%, M+), 157
(28%), 149 (13%), 132 (34%), 131 (37%), 116 (19%), 103 (13%), 97
(100%), 91 (30%); HRMS C11H14O2 178.0999 (requires 178.0994).
13 J. Cossy, L. Tresnard and L. Tresnard, Eur. J. Org. Chem., 1999, 8, 1925.
14 M. Fujita, W. H. Kim, K. Fujiwara and T. Okuyama, J. Org. Chem.,
2005, 70, 480.
15 J. M. Luche, J. Am. Chem. Soc., 1978, 100, 2226.
16 L. A. Arnold, R. Imbos, A. Mandoli, A. H. M. de Vries, R. Naasz and
B. L. Feringa, Tetrahedron, 2000, 56, 2865.
17 H. Bernsmann, M. van den Berg, R. Hoen, A. J. Minnaard, G. Mehler,
M. T. Reetz, J. G. de Vries and B. L. Feringa, J. Org. Chem., 2005, 70,
943.
18 D. Pen˜a, A. J. Minnaard, A. H. M. de Vries, J. G. de Vries and B. L.
Feringa, Org. Lett., 2003, 5, 475.
19 A. Rimkus and N. Sewald, Synthesis, 2004, 135.
(1S, 1ꢀR)(Cyclopent-2-enyl)(phenyl)methanol (16). Obtained
as a clear oil (23 mg, 66%); absolute stereochemistry assigned
by optical rotation [a]D22 +13.8 (c 1.00 in CHCl3) (lit.,22 +27.2); GC
(Chiralsil-L-val, [25.0 m × 0.25 mm], 0.50 mL min−1, initial temp.
120 ◦C for 15 min, then 5 ◦C min−1 to final temp. 160 ◦C, 22.7 min
[minor], 22.8 min [major]) shows 45% ee; 1H and 13C-NMR in full
agreement with literature.26
20 R. Hoen, M. van den Berg, H. Bernsmann, A. J. Minnaard, J. G. de
Vries and B. L. Feringa, Org. Lett., 2004, 6, 1433.
21 K. Tissot-Croset, D. Polet and A. Alexakis, Angew. Chem., Int. Ed.,
2004, 43, 2426.
22 T. Hayashi, J. W. Han, A. Takeda, J. Tang, K. Nohmi, K. Mukaide, H.
Tsuji and Y. Uozumi, Adv. Synth. Catal., 2001, 343, 279.
23 S. Kobayashi and K. Nishio, J. Org. Chem., 1994, 59, 6620.
24 F. A. Khan and B. Prabhudas, Tetrahedron, 2000, 56, 7595.
25 P. D. Ren, D. Shao and T. W. Dong, Synth. Commun., 1997, 27, 2569.
26 A. G. Griesbeck and S. Stadtmu¨ller, J. Am. Chem. Soc., 1991, 113,
6923.
(R)-1-Phenyl-but-3-en-1-ol (18). Obtained as a clear oil (22 mg,
73%); absolute stereochemistry assigned by optical rotation
27 E. J. Corey and S. S. Kim, Tetrahedron Lett., 1990, 31, 3715.
This journal is
The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 1278–1283 | 1283
©